Concepedia

Michael R. Loken

MR

146

Publications

10.7K

Citations

58

H-Index

1967

Active since

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

University of Southern California

Children's Oncology Group

St. Jude Children's Research Hospital

Michael R. Loken is an author at Fred Hutch Cancer Center specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1967–2024

146

Publications

146

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

Eric L. Sievers, Richard A. Larson, Edward A. Stadtmauer et al. · Journal of Clinical Oncology · 2001 · 882 citations

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence

Richard A. Larson, Eric L. Sievers, Edward A. Stadtmauer et al. · Cancer · 2005 · 451 citations

ANALYSIS OF CELL POPULATIONS WITH A FLUORESCENCE‐ACTIVATED CELL SORTER*

Michael R. Loken, Leonard A. Herzenberg · Annals of the New York Academy of Sciences · 1975 · 399 citations

, , +3

Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

Denise A. Wells, Martin Benesch, Michael R. Loken et al. · Blood · 2003 · 361 citations · Full text

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Michael R. Loken, Todd A. Alonzo, Laura Pardo et al. · Blood · 2012 · 291 citations · Full text

Rows per page

1–5 of 146